ES2102081T3 - Inductores de parainmunidad multipotentes basados en combinaciones de componentes de poxvirus, metodos para preparar los mismos, y su uso como farmacos. - Google Patents

Inductores de parainmunidad multipotentes basados en combinaciones de componentes de poxvirus, metodos para preparar los mismos, y su uso como farmacos.

Info

Publication number
ES2102081T3
ES2102081T3 ES94103047T ES94103047T ES2102081T3 ES 2102081 T3 ES2102081 T3 ES 2102081T3 ES 94103047 T ES94103047 T ES 94103047T ES 94103047 T ES94103047 T ES 94103047T ES 2102081 T3 ES2102081 T3 ES 2102081T3
Authority
ES
Spain
Prior art keywords
drugs
preparing
combinations
paramunity
powerful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94103047T
Other languages
English (en)
Inventor
Anton Prof Dr Med Vet Dr Mayr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2102081T3 publication Critical patent/ES2102081T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBEN INDUCTORES DE PARAINMUNIDAD MULTIPOTENTE SOBRE LA BASE DE COMBINACIONES DE COMPONENTES DE VIRUS DE BOLSILLO, QUE SE DERIVAN DE LOS VIRUS DE BOLSILLO DIFERENTES CON PROPIEDADES DE PARAINMUNIZACION Y CON REFERENCIA A SU POTENCIA Y A SUS ACTIVIDADES, QUE PARTICIPAN EN LA PARAINMUNIZACION, SE HAN MEJORADO EN RELACION A LOS INDUCTORES DE PARAINMUNIDAD CONOCIDOS. LA INVENCION SE REFIERE ADEMAS A UN PROCEDIMIENTO DE ESTOS INDUCTORES DE PARAINMUNIDAD MULTIPOTENTE ASI COMO SU UTILIZACION COMO MEDICAMENTO.
ES94103047T 1994-02-23 1994-03-01 Inductores de parainmunidad multipotentes basados en combinaciones de componentes de poxvirus, metodos para preparar los mismos, y su uso como farmacos. Expired - Lifetime ES2102081T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4405841A DE4405841C1 (de) 1994-02-23 1994-02-23 Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ES2102081T3 true ES2102081T3 (es) 1997-07-16

Family

ID=6511005

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94103047T Expired - Lifetime ES2102081T3 (es) 1994-02-23 1994-03-01 Inductores de parainmunidad multipotentes basados en combinaciones de componentes de poxvirus, metodos para preparar los mismos, y su uso como farmacos.

Country Status (20)

Country Link
US (1) US6805870B1 (es)
EP (1) EP0669133B1 (es)
JP (1) JP2873880B2 (es)
KR (1) KR100196204B1 (es)
CN (1) CN1142187A (es)
AT (1) ATE153242T1 (es)
AU (1) AU690625B2 (es)
BR (1) BR9506882A (es)
CA (1) CA2182207C (es)
DE (2) DE4405841C1 (es)
DK (1) DK0669133T3 (es)
ES (1) ES2102081T3 (es)
FI (1) FI116557B (es)
GR (1) GR3023508T3 (es)
HU (1) HU220972B1 (es)
NO (1) NO319250B1 (es)
NZ (1) NZ278079A (es)
PL (1) PL182132B1 (es)
SI (1) SI0669133T1 (es)
WO (1) WO1995022978A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59712852D1 (de) * 1996-02-28 2007-07-19 Bayer Healthcare Ag Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen
HU224308B1 (hu) * 1996-04-15 2005-07-28 Anton Mayr Attenuált, nem immunogén poxvírusokból vagy parapoxvírusokból származó multipotens parapox immunitás-inducerek alkalmazása gyógyszerkészítmények előállítására
JPH1192390A (ja) * 1997-09-17 1999-04-06 Natl Fedelation Of Agricult Coop Assoc ストレス状態改善剤
AU5036899A (en) 1998-06-26 2000-01-17 Aventis Pasteur Use of poxviruses as enhancer of specific immunity
DE19922407A1 (de) * 1999-05-14 2000-11-16 Bayer Ag Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus
DK1180155T3 (da) * 1999-05-28 2009-02-16 Helmholtz Zentrum Muenchen Vektor til integration af heterologe sekvenser i poxvirale genomer
US6682743B2 (en) * 2000-03-14 2004-01-27 Bavarian Nordic A/S Altered strain of the modified vaccinia virus ankara (MVA)
EP1303286B1 (de) * 2000-07-11 2006-04-26 Bayer HealthCare AG Verwendung von stämmen des parapoxvirus ovis zur herstellung von antiviralen arzneimitteln und arzneimitteln gegen krebs
DE10122233A1 (de) * 2000-07-11 2002-01-24 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
IL153826A0 (en) 2000-07-11 2003-07-31 Bayer Ag Use of strains of the parapox ovis virus against organ fibrosis
DE10122451A1 (de) * 2000-07-11 2002-04-04 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis zur Herstellung von antiviralen Arzneimitteln und Arzneimitteln gegen Krebs
US7628980B2 (en) 2000-11-23 2009-12-08 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
US7097842B2 (en) * 2000-11-23 2006-08-29 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
WO2004022729A1 (en) * 2002-09-05 2004-03-18 Bavarian Nordic A/S Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
EE05680B1 (et) 2000-11-23 2013-10-15 Bavarian Nordic A/S Muundatud vaktsiiniaviirus, selle valmistamine ja kasutamine, seda sisaldav farmatseutiline kompositsioon ning vaktsiin
UA82466C2 (uk) * 2001-07-18 2008-04-25 Бавариан Нордика А/С Спосіб посилення ампліфікації хордопоксвірусу
EP1456230A2 (en) 2001-12-04 2004-09-15 Bavarian Nordic A/S Flavivirus ns1 subunit vaccine
AU2002362072A1 (en) * 2001-12-07 2003-06-23 Board Of Regents The University Of Texas System Use a parapox b2l protein to modify immune responses to administered antigens
US6752995B2 (en) * 2002-04-15 2004-06-22 Board Of Regents, The University Of Texas System Nucleic acid and polypeptide sequences useful as adjuvants
US6723329B2 (en) * 2001-12-07 2004-04-20 Board Of Regents, The University Of Texas System Use of parapox B2L protein to modify immune responses to administered antigens
AU2003239805B2 (en) 2002-04-19 2009-09-10 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
DE102004003572A1 (de) 2004-01-23 2005-08-18 Bavarian Nordic A/S Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens
PL1765370T3 (pl) * 2004-07-13 2010-02-26 Aicuris Gmbh & Co Kg Parapoksywirusy w kombinacji z innymi czynnikami przeciwwirusowymi do leczenia HIV/AIDS
DE102004046391A1 (de) * 2004-09-24 2006-04-06 Bioveta Ag Neuer Impfstoff für veterinäre und humanmedizinische Prophylaxe und Therapie
DE102005027956B4 (de) * 2005-06-16 2009-10-22 Mayr, Anton, Prof. Dr. Dr. h.c. mult. Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen
US20140255447A1 (en) * 2013-03-05 2014-09-11 Biomune Company Production of avian embryo cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3816139A1 (de) * 1987-10-17 1989-04-27 Bayer Ag Verfahren zur herstellung von paramunitaetsinducern

Also Published As

Publication number Publication date
JPH09504803A (ja) 1997-05-13
KR970701062A (ko) 1997-03-17
SI0669133T1 (en) 1997-10-31
PL316024A1 (en) 1996-12-23
NO963462L (no) 1996-08-20
EP0669133B1 (de) 1997-05-21
DK0669133T3 (da) 1997-07-14
AU1416795A (en) 1995-09-11
CA2182207A1 (en) 1995-08-31
AU690625B2 (en) 1998-04-30
FI963277A0 (fi) 1996-08-22
HU9601947D0 (en) 1996-09-30
ATE153242T1 (de) 1997-06-15
EP0669133A1 (de) 1995-08-30
FI116557B (fi) 2005-12-30
NZ278079A (en) 1998-01-26
FI963277A (fi) 1996-08-22
US6805870B1 (en) 2004-10-19
KR100196204B1 (ko) 1999-06-15
WO1995022978A1 (en) 1995-08-31
PL182132B1 (pl) 2001-11-30
CA2182207C (en) 2000-02-29
JP2873880B2 (ja) 1999-03-24
DE4405841C1 (de) 1995-01-05
GR3023508T3 (en) 1997-08-29
DE59402826D1 (de) 1997-06-26
NO319250B1 (no) 2005-07-04
HUT75545A (en) 1997-05-28
HU220972B1 (hu) 2002-07-29
CN1142187A (zh) 1997-02-05
BR9506882A (pt) 1997-08-19

Similar Documents

Publication Publication Date Title
ES2102081T3 (es) Inductores de parainmunidad multipotentes basados en combinaciones de componentes de poxvirus, metodos para preparar los mismos, y su uso como farmacos.
MX9203279A (es) 1-aril-2-acilamido-3-fluoro-1-propanoles, metodos para su uso como agentes antibacterianos y composiciones utiles de los mismos.
ES2053719T3 (es) Dimetilvermectinas no naturales y procedimiento para su preparacion.
BR9713520B1 (pt) iminas cìclicas, composição praguicida, processo para preparação e uso das referidas iminas cìclicas e da composição praguicida, bem como processo para combater pragas.
ES2194106T3 (es) .ompuestos de imidazol
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
MX9305833A (es) Procedimiento para la preparacion de pirrolo[2,3-d]pirimidinas 5-sustituidas.
BR9003272A (pt) Panela intermediaria,revestimento de panela intermediaria e metodo para preparacao do mesmo
DK0952772T3 (da) Fremgangsmåder til anvendelse af mononukleare phagocytter til at fremme axonal regeneration
ES2190801T3 (es) Nuevos complejos de bis-platino con ligandos de poliamina como agentes antitumorales.
ES2187799T3 (es) Complejos de bis-platino con derivados de polimetileno como ligandos que tienen actividad antitumoral.
AR005619A1 (es) Procedimiento para preparar compuestos dicetonicos
ES2016642B3 (es) Composiciones de olefinas polisulfuradas, su preparacion y su utilizacion como aditivos para lubricantes.
AR005704A1 (es) Heteroariloxazolidinonas
AT372832B (de) Baukastensystem zur erstellung von baenken, tischen od. dgl.
AR227050A1 (es) Nuevas metafenilendiaminas,procedimiento para su preparacion y composiciones tintoreas para fibras queratinicas que las contienen
ES2183890T3 (es) Uso del factor de crecimiento de hepatocitos para in estimular la proliferacion y diferenciacion de celulas hematopoyeticas.
ES2166026T3 (es) Derivados de 1,2,3-benzotiadiazol y su uso como microbicidas.
IT7823159A0 (it) Nuovi 1-acil-2-idrossi-1,3-diamminopropani, procedimento per prepararli e preparati che licontengono.
PE20399A1 (es) Muteina ob
ES499151A0 (es) Procedimiento para la preparacion de medios protectores y conservadores de madera.
ES2017983B3 (es) Compuestos diazoicos hidrosolubles, procedimientos para su obtencion y su aplicacion como colorantes.
ES2025222B3 (es) Compuestos azoicos hidrosolubles, procedimiento para su obtencion y su aplicacion como colorantes.
MX23261A (es) Derivados de piridina, procedimientos para su preparacion, agentes que los contienen y su utilizacion como fungicidas.
MX9100070A (es) Compuestos diazoicos,procedimientos para su preparacion y su utilizacion como colorantes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 669133

Country of ref document: ES